Clinical Trials
47 trialsGerman Adrenocortical Carcinoma Registry
University of Wuerzburg
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
University of Wuerzburg
Evaluation of Side Effects of Mitotane
University of Wuerzburg
Adrenal Tumors - Pathogenesis and Therapy
University of Wuerzburg
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Columbia University
SJFAMILY
St. Jude Children's Research Hospital
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Memorial Sloan Kettering Cancer Center
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Shanghai Jiao Tong University School of Medicine
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Memorial Sloan Kettering Cancer Center
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
Emory University
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Dana-Farber Cancer Institute
CCSTR
University Hospital, Strasbourg, France
SERENDIPITY
University Medical Center Groningen
Pan-MSI-ACSE
UNICANCER
INTERVAL
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.
Sun Yat-sen University
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
M.D. Anderson Cancer Center
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
West China Hospital
Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma
Sun Yat-sen University
PEMBR-01
Maria Sklodowska-Curie National Research Institute of Oncology
CaboACC
Wuerzburg University Hospital
ACACIA
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
PESETA
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
West China Hospital
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data
Seoul National University Hospital
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
University Hospital Olomouc
MEET
Shanghai Jiao Tong University School of Medicine
LACC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MitoS-FP
King's College Hospital NHS Trust
AVS for ACC
Erasmus Medical Center
First-in-human Evaluation of [18F]CETO
Uppsala University
A Prospective Cohort Study for Patients With Adrenal Diseases
Seoul National University Hospital
COMETETACTIC
Assistance Publique - Hôpitaux de Paris
SIRAC
University of Wuerzburg
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Burzynski Research Institute
CabACC
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
ABACUS
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
ADIUVO
University of Turin, Italy
Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Spanish Oncology Genito-Urinary Group
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Collaborative Group for Adrenocortical Carcinoma Treatment
Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
M.D. Anderson Cancer Center
Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
Rigshospitalet, Denmark
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
University of Wuerzburg
PAXO
University of Turin, Italy